Literature DB >> 22931256

Brain amyloid imaging--FDA approval of florbetapir F18 injection.

Lucie Yang1, Dwaine Rieves, Charles Ganley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22931256     DOI: 10.1056/NEJMp1208061

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  52 in total

1.  Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis.

Authors:  Hee Jin Kim; Jeonghun Kim; Hanna Cho; Byoung Seok Ye; Cindy W Yoon; Young Noh; Geon Ha Kim; Jae Hong Lee; Jae Seung Kim; Yearn Seong Choe; Kyung-Han Lee; Chang-Hun Kim; Sang Won Seo; Michael W Weiner; Duk L Na; Joon-Kyung Seong
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

2.  2012: A watershed year for Alzheimer's disease research.

Authors:  M Grundman; A Dibernardo; N Raghavan; M Krams; E Yuen
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

3.  Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

Authors:  Sharmila Dorbala; Divya Vangala; James Semer; Christopher Strader; John R Bruyere; Marcelo F Di Carli; Stephen C Moore; Rodney H Falk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

4.  Patient and Caregiver Assessment of the Benefits From the Clinical Use of Amyloid PET Imaging.

Authors:  Rafid Mustafa; Jared R Brosch; Gil D Rabinovici; Bradford C Dickerson; Maria C Carrillo; Bradley S Glazier; Sujuan Gao; Martha Tierney; Keith N Fargo; Mary G Austrom; Susan De Santi; David G Clark; Liana G Apostolova
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jan-Mar       Impact factor: 2.703

5.  [Molecular imaging in neurological diseases].

Authors:  M Reimold; C la Fougère
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

6.  Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.

Authors:  Nathan O Solberg; Ryan Chamberlin; Jenette R Vigil; Lorraine M Deck; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; Marco Bisoffi; Virginia Severns; David L Vander Jagt; Laurel O Sillerud
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Practical utility of amyloid and FDG-PET in an academic dementia center.

Authors:  Pascual Sánchez-Juan; Pia M Ghosh; Jayne Hagen; Benno Gesierich; Maya Henry; Lea T Grinberg; James P O'Neil; Mustafa Janabi; Eric J Huang; John Q Trojanowski; Harry V Vinters; Marilu Gorno-Tempini; William W Seeley; Adam L Boxer; Howard J Rosen; Joel H Kramer; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Neurology       Date:  2013-12-18       Impact factor: 9.910

8.  Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls.

Authors:  Masahiro Maruyama; Hitoshi Shimada; Tetsuya Suhara; Hitoshi Shinotoh; Bin Ji; Jun Maeda; Ming-Rong Zhang; John Q Trojanowski; Virginia M-Y Lee; Maiko Ono; Kazuto Masamoto; Harumasa Takano; Naruhiko Sahara; Nobuhisa Iwata; Nobuyuki Okamura; Shozo Furumoto; Yukitsuka Kudo; Qing Chang; Takaomi C Saido; Akihiko Takashima; Jada Lewis; Ming-Kuei Jang; Ichio Aoki; Hiroshi Ito; Makoto Higuchi
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

9.  Anatomy-guided brain PET imaging incorporating a joint prior model.

Authors:  Lijun Lu; Jianhua Ma; Qianjin Feng; Wufan Chen; Arman Rahmim
Journal:  Phys Med Biol       Date:  2015-02-16       Impact factor: 3.609

10.  SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.

Authors:  Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.